Biotechnology
The Biotechnology industry has a total of 591 stocks, with a combined market cap of $1.2 trillion and total revenue of $110.17 billion.
Market Cap
1.2T
Revenue
110.17B
Profits
-39.86B
PE Ratio
n/a
Profit Margin
-36.19%
Dividend Yield
0.04%
591 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.35B | 0.11% | 131,419 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 77.16B | 0.18% | 113,978 | 14.34B |
| 3 | ARGX | argenx SE | 52.70B | -1.71% | 66,358 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 41.33B | 0.64% | 241,085 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 35.34B | -1.60% | 46,212 | 5.34B |
| 6 | RVMD | Revolution Medicines, Inc. | 31.55B | 0.92% | 790,956 | - |
| 7 | INSM | Insmed Incorporated | 30.73B | -1.46% | 271,935 | 606.42M |
| 8 | RPRX | Royalty Pharma plc | 29.57B | -0.24% | 787,967 | 2.38B |
| 9 | BNTX | BioNTech SE | 26.44B | 1.59% | 330,220 | 3.37B |
| 10 | MRNA | Moderna, Inc. | 21.46B | 0.71% | 2,335,924 | 1.94B |
| 11 | ROIV | Roivant Sciences Ltd. | 21.22B | -0.59% | 1,680,341 | 13.31M |
| 12 | INCY | Incyte Corporation | 19.45B | -0.11% | 238,257 | 5.14B |
| 13 | SMMT | Summit Therapeutics Inc. | 19.27B | -1.19% | 1,340,523 | - |
| 14 | GMAB | Genmab A/S | 17.49B | -1.54% | 962,202 | 3.72B |
| 15 | ASND | Ascendis Pharma A/S | 15.25B | 0.99% | 69,473 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.81B | -0.46% | 179,943 | 502.08M |
| 17 | JAZZ | Jazz Pharmaceuticals plc | 12.66B | 1.10% | 179,725 | 4.27B |
| 18 | IONS | Ionis Pharmaceuticals, Inc. | 12.35B | -1.23% | 275,657 | 943.71M |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.06B | -1.17% | 45,837 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.55B | -0.94% | 367,637 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 10.60B | 0.84% | 344,475 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.79B | -1.90% | 259,749 | 5.37M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.73B | -0.01% | 180,464 | 1.09B |
| 24 | AXSM | Axsome Therapeutics, Inc. | 9.66B | -0.05% | 132,805 | 638.50M |
| 25 | PRAX | Praxis Precision Medicines, Inc. | 9.57B | 0.36% | 118,640 | 7.46M |
| 26 | TECH | Bio-Techne Corporation | 9.36B | 0.96% | 374,566 | 1.22B |
| 27 | PCVX | Vaxcyte, Inc. | 8.99B | 0.16% | 241,367 | - |
| 28 | NUVL | Nuvalent, Inc. | 8.49B | 0.35% | 78,809 | - |
| 29 | IBRX | ImmunityBio, Inc. | 8.41B | 5.78% | 7,426,750 | 113.29M |
| 30 | HALO | Halozyme Therapeutics, Inc. | 8.19B | -0.22% | 191,937 | 1.40B |
| 31 | CYTK | Cytokinetics, Incorporated | 8.13B | -1.02% | 185,695 | 88.04M |
| 32 | KRYS | Krystal Biotech, Inc. | 8.06B | -0.14% | 39,533 | 389.13M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.19B | 0.35% | 78,215 | 39.21M |
| 34 | APGE | Apogee Therapeutics, Inc. | 6.75B | -0.86% | 149,330 | - |
| 35 | ACLX | Arcellx, Inc. | 6.75B | -0.03% | 230,621 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.73B | -0.52% | 46,755 | 46.02M |
| 37 | BLTE | Belite Bio, Inc | 6.41B | -1.48% | 19,939 | - |
| 38 | SYRE | Spyre Therapeutics, Inc. | 6.41B | 1.74% | 146,397 | - |
| 39 | ERAS | Erasca, Inc. | 6.26B | 5.94% | 1,356,812 | - |
| 40 | CNTA | Centessa Pharmaceuticals plc | 6.12B | -0.28% | 661,909 | 15.00M |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.12B | 0.99% | 76,188 | 189.76M |
| 42 | TERN | Terns Pharmaceuticals, Inc. | 6.09B | 0.12% | 1,791,782 | - |
| 43 | CGON | CG Oncology, Inc. | 6.08B | -1.98% | 191,648 | 4.04M |
| 44 | COGT | Cogent Biosciences, Inc. | 6.02B | 0.43% | 367,079 | - |
| 45 | CAI | Caris Life Sciences, Inc. | 5.99B | 0.28% | 261,501 | 812.03M |
| 46 | PTCT | PTC Therapeutics, Inc. | 5.99B | -0.17% | 84,911 | 1.73B |
| 47 | MIRM | Mirum Pharmaceuticals, Inc. | 5.88B | -0.49% | 49,485 | 521.31M |
| 48 | IMVT | Immunovant, Inc. | 5.86B | -1.81% | 268,199 | - |
| 49 | CELC | Celcuity Inc. | 5.82B | -1.73% | 82,091 | - |
| 50 | SRRK | Scholar Rock Holding Corporation | 5.62B | -2.10% | 193,925 | - |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.53B | -2.88% | 335,011 | 7.50M |
| 52 | CRSP | CRISPR Therapeutics AG | 5.51B | -1.03% | 390,241 | 3.51M |
| 53 | TGTX | TG Therapeutics, Inc. | 5.24B | 0.42% | 327,261 | 616.29M |
| 54 | APLS | Apellis Pharmaceuticals, Inc. | 5.23B | -0.05% | 850,963 | 1.00B |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 5.03B | -0.86% | 143,028 | 2.04M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.81B | -1.95% | 155,302 | 761.41M |
| 57 | LGND | Ligand Pharmaceuticals Incorporated | 4.61B | -0.22% | 26,318 | 268.09M |
| 58 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.03% | 203,263 | 634.21M |
| 59 | LEGN | Legend Biotech Corporation | 4.35B | 11.01% | 1,484,980 | 1.03B |
| 60 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.23B | -1.38% | 156,881 | 7.70M |
| 61 | VKTX | Viking Therapeutics, Inc. | 4.02B | -1.39% | 676,676 | - |
| 62 | NAMS | NewAmsterdam Pharma Company N.V. | 3.98B | -0.26% | 89,610 | 22.50M |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.80B | 0.50% | 214,118 | 1.07B |
| 64 | TNGX | Tango Therapeutics, Inc. | 3.75B | -1.35% | 305,211 | 62.38M |
| 65 | TVTX | Travere Therapeutics, Inc. | 3.71B | -1.37% | 686,701 | 490.73M |
| 66 | EWTX | Edgewise Therapeutics, Inc. | 3.69B | 0.01% | 84,381 | - |
| 67 | TLX | Telix Pharmaceuticals Limited | 3.60B | -0.88% | 58,041 | 803.79M |
| 68 | GPCR | Structure Therapeutics Inc. | 3.50B | -2.65% | 140,623 | - |
| 69 | ORKA | Oruka Therapeutics, Inc. | 3.43B | 0.54% | 280,962 | - |
| 70 | DYN | Dyne Therapeutics, Inc. | 3.31B | -1.81% | 353,073 | - |
| 71 | KLRA | Kailera Therapeutics, Inc. | 3.31B | 2.92% | 508,126 | - |
| 72 | DNLI | Denali Therapeutics Inc. | 3.27B | 0.39% | 222,145 | - |
| 73 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.18B | -0.76% | 263,461 | 588.99M |
| 74 | ALMS | Alumis Inc. | 3.14B | -1.32% | 114,205 | 24.05M |
| 75 | BEAM | Beam Therapeutics Inc. | 3.10B | -0.45% | 383,567 | 139.74M |
| 76 | VERA | Vera Therapeutics, Inc. | 3.04B | 0.21% | 140,351 | - |
| 77 | NKTR | Nektar Therapeutics | 3.03B | 24.56% | 2,692,007 | 55.23M |
| 78 | ARQT | Arcutis Biotherapeutics, Inc. | 3.00B | -1.53% | 161,506 | 376.07M |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.95B | -0.86% | 85,470 | 218.71M |
| 80 | RLAY | Relay Therapeutics, Inc. | 2.89B | -3.40% | 887,496 | 15.36M |
| 81 | RCUS | Arcus Biosciences, Inc. | 2.88B | -5.15% | 454,915 | 247.00M |
| 82 | ELVN | Enliven Therapeutics, Inc. | 2.83B | -1.60% | 107,920 | - |
| 83 | ZLAB | Zai Lab Limited | 2.81B | 3.10% | 412,628 | 460.16M |
| 84 | IMNM | Immunome, Inc. | 2.80B | 0.45% | 134,964 | 6.94M |
| 85 | KOD | Kodiak Sciences Inc. | 2.79B | 0.82% | 208,489 | - |
| 86 | TARS | Tarsus Pharmaceuticals, Inc. | 2.77B | -3.32% | 124,285 | 451.36M |
| 87 | IRON | Disc Medicine, Inc. | 2.74B | -0.08% | 41,891 | - |
| 88 | MANE | Veradermics, Incorporated | 2.73B | -4.05% | 103,614 | - |
| 89 | SLNO | Soleno Therapeutics, Inc. | 2.73B | -0.15% | 1,229,150 | 190.41M |
| 90 | CLDX | Celldex Therapeutics, Inc. | 2.72B | 0.17% | 282,520 | 1.55M |
| 91 | ADMA | ADMA Biologics, Inc. | 2.57B | -1.91% | 1,322,460 | 510.17M |
| 92 | MLYS | Mineralys Therapeutics, Inc. | 2.47B | -1.93% | 123,155 | - |
| 93 | RARE | Ultragenyx Pharmaceutical Inc. | 2.44B | 0.24% | 294,724 | 673.00M |
| 94 | AAPG | Ascentage Pharma Group International | 2.42B | -3.80% | 1,537 | 82.08M |
| 95 | DFTX | Definium Therapeutics, Inc. | 2.29B | 1.41% | 2,833,170 | - |
| 96 | ADPT | Adaptive Biotechnologies Corporation | 2.25B | 0.90% | 380,990 | 276.98M |
| 97 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | 0.07% | 426,709 | 158.18M |
| 98 | SRPT | Sarepta Therapeutics, Inc. | 2.22B | -2.04% | 500,383 | 2.20B |
| 99 | TRVI | Trevi Therapeutics, Inc. | 2.18B | 2.10% | 923,074 | - |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.14B | -2.74% | 100,690 | 184.42M |
| 101 | MESO | Mesoblast Limited | 2.14B | 1.52% | 77,749 | 65.38M |
| 102 | AUPH | Aurinia Pharmaceuticals Inc. | 2.12B | -0.44% | 190,851 | 283.06M |
| 103 | SNDX | Syndax Pharmaceuticals, Inc. | 2.12B | -0.62% | 163,053 | 172.35M |
| 104 | OCUL | Ocular Therapeutix, Inc. | 2.09B | -2.39% | 637,145 | 51.95M |
| 105 | CAPR | Capricor Therapeutics, Inc. | 2.08B | 3.63% | 315,150 | 11.13M |
| 106 | ZYME | Zymeworks Inc. | 2.05B | -0.18% | 63,615 | 105.97M |
| 107 | RXRX | Recursion Pharmaceuticals, Inc. | 1.96B | -1.72% | 3,608,790 | 74.68M |
| 108 | SION | Sionna Therapeutics, Inc. | 1.96B | 0.07% | 130,659 | - |
| 109 | GLPG | Galapagos NV | 1.92B | 0.44% | 26,498 | 1.31B |
| 110 | PHVS | Pharvaris N.V. | 1.90B | 1.57% | 22,723 | - |
| 111 | TSHA | Taysha Gene Therapies, Inc. | 1.88B | 2.02% | 914,793 | 9.77M |
| 112 | TYRA | Tyra Biosciences, Inc. | 1.88B | -1.66% | 292,697 | - |
| 113 | ATAI | AtaiBeckley Inc. | 1.85B | 25.81% | 31,433,223 | 4.09M |
| 114 | PVLA | Palvella Therapeutics, Inc. | 1.84B | -1.15% | 50,124 | - |
| 115 | VCEL | Vericel Corporation | 1.81B | -0.56% | 109,426 | 276.26M |
| 116 | RAPP | Rapport Therapeutics, Inc. | 1.80B | -5.14% | 44,163 | - |
| 117 | INVA | Innoviva, Inc. | 1.79B | -0.25% | 105,301 | 411.33M |
| 118 | NRIX | Nurix Therapeutics, Inc. | 1.79B | -1.37% | 135,165 | 71.78M |
| 119 | VIR | Vir Biotechnology, Inc. | 1.76B | 2.70% | 1,096,512 | 68.56M |
| 120 | NUVB | Nuvation Bio Inc. | 1.76B | -0.49% | 941,013 | 62.90M |
| 121 | NTLA | Intellia Therapeutics, Inc. | 1.75B | -0.87% | 864,852 | 67.67M |
| 122 | OCS | Oculis Holding AG | 1.72B | 5.61% | 380,733 | 1.51M |
| 123 | HRMY | Harmony Biosciences Holdings, Inc. | 1.67B | -3.73% | 208,154 | 868.45M |
| 124 | NBTX | Nanobiotix S.A. | 1.64B | -4.50% | 8,738 | 38.27M |
| 125 | DMRA | Damora Therapeutics, Inc. | 1.63B | 1.50% | 82,890 | - |
| 126 | BHVN | Biohaven Ltd. | 1.61B | -2.46% | 449,551 | - |
| 127 | GLUE | Monte Rosa Therapeutics, Inc. | 1.60B | 1.31% | 189,967 | 123.67M |
| 128 | IOVA | Iovance Biotherapeutics, Inc. | 1.58B | -0.78% | 5,136,860 | 263.50M |
| 129 | IMCR | Immunocore Holdings plc | 1.57B | -1.24% | 44,464 | 400.02M |
| 130 | AGIO | Agios Pharmaceuticals, Inc. | 1.57B | -23.76% | 2,502,471 | 54.03M |
| 131 | ARDX | Ardelyx, Inc. | 1.56B | -1.24% | 1,083,108 | 407.32M |
| 132 | MBX | MBX Biosciences, Inc. | 1.55B | -3.35% | 128,153 | - |
| 133 | GENB | Generate Biomedicines, Inc. | 1.55B | -2.37% | 98,165 | 31.89M |
| 134 | BCAX | Bicara Therapeutics Inc. | 1.54B | -2.25% | 81,614 | - |
| 135 | VRDN | Viridian Therapeutics, Inc. | 1.53B | 1.35% | 224,503 | 70.85M |
| 136 | IMTX | Immatics N.V. | 1.50B | -0.18% | 50,263 | 56.67M |
| 137 | OLMA | Olema Pharmaceuticals, Inc. | 1.49B | 1.90% | 263,327 | - |
| 138 | PGEN | Precigen, Inc. | 1.49B | 6.03% | 1,585,548 | 9.68M |
| 139 | ANAB | AnaptysBio, Inc. | 1.47B | -24.44% | 355,906 | 234.60M |
| 140 | SVRA | Savara Inc. | 1.43B | -2.25% | 219,434 | - |
| 141 | WVE | Wave Life Sciences Ltd. | 1.41B | 0.20% | 876,413 | 42.73M |
| 142 | NVAX | Novavax, Inc. | 1.41B | -2.04% | 751,973 | 1.12B |
| 143 | MAZE | Maze Therapeutics, Inc. | 1.39B | -0.14% | 143,298 | 2.50M |
| 144 | GHRS | GH Research PLC | 1.34B | 18.10% | 804,015 | - |
| 145 | CRVS | Corvus Pharmaceuticals, Inc. | 1.34B | -4.48% | 445,118 | - |
| 146 | AVBP | ArriVent BioPharma, Inc. | 1.33B | 1.89% | 150,594 | - |
| 147 | MLTX | MoonLake Immunotherapeutics | 1.29B | -2.13% | 140,311 | - |
| 148 | MPLT | MapLight Therapeutics, Inc. | 1.29B | -2.76% | 45,716 | - |
| 149 | ZBIO | Zenas BioPharma, Inc. | 1.27B | -1.83% | 90,866 | 10.00M |
| 150 | EYPT | EyePoint, Inc. | 1.27B | 1.74% | 111,762 | 31.37M |
| 151 | DBVT | DBV Technologies S.A. | 1.27B | -2.30% | 170,795 | 5.64M |
| 152 | PHAR | Pharming Group N.V. | 1.24B | 0.87% | 6,174 | 376.13M |
| 153 | INBX | Inhibrx Biosciences, Inc. | 1.21B | -5.76% | 110,028 | 1.30M |
| 154 | ABCL | AbCellera Biologics Inc. | 1.20B | -1.62% | 2,184,554 | 75.13M |
| 155 | IVA | Inventiva S.A. | 1.18B | 0.88% | 134,391 | 7.94M |
| 156 | SEPN | Septerna, Inc. | 1.16B | -1.34% | 65,650 | 45.95M |
| 157 | AKTS | Aktis Oncology, Inc. | 1.14B | 1.88% | 41,598 | 6.50M |
| 158 | QURE | uniQure N.V. | 1.13B | 1.93% | 424,272 | 16.10M |
| 159 | JBIO | Jade Biosciences, Inc. | 1.13B | - | 86,699 | - |
| 160 | ORIC | ORIC Pharmaceuticals, Inc. | 1.09B | 0.84% | 254,905 | - |
| 161 | URGN | UroGen Pharma Ltd. | 1.08B | -1.60% | 202,583 | 109.79M |
| 162 | XERS | Xeris Biopharma Holdings, Inc. | 1.07B | -2.51% | 344,415 | 291.85M |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 1.06B | 1.52% | 151,167 | 175.11M |
| 164 | KALV | KalVista Pharmaceuticals, Inc. | 1.06B | 1.03% | 150,062 | 73.62M |
| 165 | CTMX | CytomX Therapeutics, Inc. | 1.06B | 1.66% | 1,039,710 | 76.20M |
| 166 | ANNX | Annexon, Inc. | 1.04B | -1.07% | 369,453 | - |
| 167 | GERN | Geron Corporation | 1.02B | -5.06% | 6,618,866 | 183.88M |
| 168 | CMPX | Compass Therapeutics, Inc. | 1.01B | -6.67% | 989,955 | 850.00K |
| 169 | EVMN | Evommune, Inc. | 984.02M | -0.47% | 77,786 | 13.00M |
| 170 | JANX | Janux Therapeutics, Inc. | 971.48M | 0.95% | 470,611 | 10.00M |
| 171 | SANA | Sana Biotechnology, Inc. | 968.54M | 0.28% | 567,036 | - |
| 172 | FTRE | Fortrea Holdings Inc. | 963.99M | -0.67% | 91,238 | 2.72B |
| 173 | MGTX | MeiraGTx Holdings plc | 955.19M | 1.98% | 354,704 | 81.39M |
| 174 | OMER | Omeros Corporation | 953.95M | -1.41% | 257,434 | - |
| 175 | XNCR | Xencor, Inc. | 953.40M | -0.46% | 198,916 | 125.58M |
| 176 | SLS | SELLAS Life Sciences Group, Inc. | 951.79M | 1.53% | 2,562,798 | - |
| 177 | ANRO | Alto Neuroscience, Inc. | 945.02M | -2.74% | 72,106 | - |
| 178 | ABUS | Arbutus Biopharma Corporation | 908.88M | -2.22% | 135,391 | 14.08M |
| 179 | LBRX | LB Pharmaceuticals Inc | 898.67M | 2.69% | 30,571 | - |
| 180 | MNKD | MannKind Corporation | 895.51M | 2.11% | 965,401 | 348.97M |
| 181 | MRVI | Maravai LifeSciences Holdings, Inc. | 892.02M | 2.36% | 657,922 | 185.74M |
| 182 | DRUG | Bright Minds Biosciences Inc. | 884.14M | -0.83% | 22,614 | - |
| 183 | TBPH | Theravance Biopharma, Inc. | 882.59M | -0.52% | 68,239 | 107.46M |
| 184 | CGEM | Cullinan Therapeutics, Inc. | 876.12M | -3.88% | 185,242 | - |
| 185 | KURA | Kura Oncology, Inc. | 867.21M | 0.93% | 431,969 | 67.48M |
| 186 | ALLO | Allogene Therapeutics, Inc. | 863.38M | 5.02% | 4,701,174 | 22.00K |
| 187 | SLDB | Solid Biosciences Inc. | 847.18M | -0.23% | 136,380 | - |
| 188 | VOR | Vor Biopharma Inc. | 836.08M | -6.99% | 461,163 | - |
| 189 | FBRX | Forte Biosciences, Inc. | 821.98M | -1.00% | 34,763 | - |
| 190 | SGP | SpyGlass Pharma, Inc. | 820.96M | -1.52% | 10,662 | - |
| 191 | DSGN | Design Therapeutics, Inc. | 809.76M | 0.08% | 49,282 | - |
| 192 | SPRY | ARS Pharmaceuticals, Inc. | 805.30M | -0.86% | 232,357 | 84.28M |
| 193 | RLMD | Relmada Therapeutics, Inc. | 784.56M | - | 1,003,654 | - |
| 194 | LXRX | Lexicon Pharmaceuticals, Inc. | 771.10M | -2.67% | 832,280 | 49.80M |
| 195 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 742.30M | -0.80% | 73,361 | - |
| 196 | TENX | Tenax Therapeutics, Inc. | 729.36M | 0.35% | 120,530 | - |
| 197 | CBIO | Crescent Biopharma, Inc. | 721.07M | 2.02% | 33,671 | 10.84M |
| 198 | GYRE | Gyre Therapeutics, Inc. | 719.55M | -2.72% | 19,733 | 116.59M |
| 199 | DRTS | Alpha Tau Medical Ltd. | 712.00M | 0.75% | 127,943 | - |
| 200 | ARVN | Arvinas, Inc. | 699.09M | -0.64% | 139,989 | 262.60M |
| 201 | PRME | Prime Medicine, Inc. | 662.28M | -1.84% | 308,942 | 4.63M |
| 202 | EIKN | Eikon Therapeutics, Inc. | 647.50M | 0.50% | 58,628 | - |
| 203 | PROK | ProKidney Corp. | 640.06M | -2.75% | 265,502 | 893.00K |
| 204 | KYTX | Kyverna Therapeutics, Inc. | 635.57M | 5.74% | 1,018,318 | - |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 627.04M | 0.09% | 160,821 | 106.47M |
| 206 | OCGN | Ocugen, Inc. | 616.66M | -8.29% | 8,109,126 | 4.41M |
| 207 | STTK | Shattuck Labs, Inc. | 612.21M | 7.57% | 257,036 | 1.00M |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 609.06M | 1.67% | 57,386 | 294.28M |
| 209 | ANL | Adlai Nortye Ltd. | 603.20M | -5.81% | 148,625 | 5.00M |
| 210 | CRMD | CorMedix Inc. | 594.46M | 1.76% | 314,308 | 311.71M |
| 211 | PRTA | Prothena Corporation plc | 583.55M | -0.55% | 80,477 | 9.68M |
| 212 | ACRS | Aclaris Therapeutics, Inc. | 581.00M | -1.65% | 287,441 | 7.83M |
| 213 | ABSI | Absci Corporation | 579.95M | 5.87% | 2,057,838 | 2.80M |
| 214 | LYEL | Lyell Immunopharma, Inc. | 562.45M | 0.42% | 15,055 | 36.00K |
| 215 | VSTM | Verastem, Inc. | 560.44M | -3.04% | 842,640 | 30.91M |
| 216 | CADL | Candel Therapeutics, Inc. | 548.62M | 17.58% | 2,830,368 | - |
| 217 | ADCT | ADC Therapeutics SA | 547.56M | 0.70% | 86,250 | 81.36M |
| 218 | ENGN | enGene Therapeutics Inc. | 541.94M | 0.25% | 44,790 | - |
| 219 | IMMX | Immix Biopharma, Inc. | 535.95M | -2.32% | 223,625 | - |
| 220 | UPB | Upstream Bio, Inc. | 535.49M | -1.50% | 73,375 | 2.85M |
| 221 | STRO | Sutro Biopharma, Inc. | 534.62M | 2.28% | 67,369 | 102.48M |
| 222 | TECX | Tectonic Therapeutic, Inc. | 534.20M | -3.59% | 42,120 | - |
| 223 | VALN | Valneva SE | 531.45M | 3.52% | 176,137 | 205.07M |
| 224 | FULC | Fulcrum Therapeutics, Inc. | 529.47M | -4.10% | 255,156 | 80.00M |
| 225 | ZURA | Zura Bio Limited | 524.69M | -4.82% | 599,685 | - |
| 226 | FDMT | 4D Molecular Therapeutics, Inc. | 524.30M | -2.10% | 133,847 | 85.21M |
| 227 | AGMB | AgomAb Therapeutics NV | 521.48M | -5.56% | 58,061 | - |
| 228 | LXEO | Lexeo Therapeutics, Inc. | 498.61M | -2.60% | 218,243 | - |
| 229 | TRDA | Entrada Therapeutics, Inc. | 498.24M | -1.07% | 18,547 | 25.42M |
| 230 | LRMR | Larimar Therapeutics, Inc. | 494.48M | -0.83% | 325,655 | - |
| 231 | CTNM | Contineum Therapeutics, Inc. | 489.10M | -3.18% | 37,683 | - |
| 232 | MDXG | MiMedx Group, Inc. | 488.78M | -3.66% | 614,735 | 418.63M |
| 233 | RGNX | REGENXBIO Inc. | 488.56M | -0.26% | 252,743 | 170.44M |
| 234 | BNTC | Benitec Biopharma Inc. | 479.91M | -0.50% | 8,513 | - |
| 235 | IVVD | Invivyd, Inc. | 479.35M | -2.59% | 644,211 | 53.43M |
| 236 | XOMA | XOMA Royalty Corporation | 467.33M | -1.23% | 39,047 | 52.15M |
| 237 | VTVT | vTv Therapeutics Inc. | 464.98M | -1.71% | 13,604 | 17.00K |
| 238 | AURA | Aura Biosciences, Inc. | 461.56M | -1.30% | 91,985 | - |
| 239 | AVIR | Atea Pharmaceuticals, Inc. | 457.32M | - | 52,979 | - |
| 240 | DNA | Ginkgo Bioworks Holdings, Inc. | 455.18M | -2.62% | 292,724 | 170.16M |
| 241 | ALT | Altimmune, Inc. | 450.16M | -1.14% | 740,314 | 41.00K |
| 242 | ASMB | Assembly Biosciences, Inc. | 447.17M | -3.59% | 33,766 | 72.30M |
| 243 | IPSC | Century Therapeutics, Inc. | 444.81M | -4.81% | 437,549 | 109.16M |
| 244 | NGNE | Neurogene Inc. | 443.71M | 2.30% | 32,740 | 925.00K |
| 245 | CLYM | Climb Bio, Inc. | 438.34M | 0.18% | 70,531 | - |
| 246 | EPRX | Eupraxia Pharmaceuticals Inc. | 438.18M | -0.42% | 29,073 | - |
| 247 | PRTC | PureTech Health plc | 436.90M | 0.33% | 585 | 6.39M |
| 248 | VNDA | Vanda Pharmaceuticals Inc. | 427.35M | -0.55% | 204,802 | 216.11M |
| 249 | RCKT | Rocket Pharmaceuticals, Inc. | 425.58M | -0.26% | 401,576 | - |
| 250 | ARMP | Armata Pharmaceuticals, Inc. | 423.11M | 0.43% | 8,576 | 4.90M |
| 251 | LCTX | Lineage Cell Therapeutics, Inc. | 419.71M | -1.46% | 267,410 | 14.56M |
| 252 | AUTL | Autolus Therapeutics plc | 417.84M | -1.88% | 396,307 | 75.39M |
| 253 | PALI | Palisade Bio, Inc. | 408.51M | 1.67% | 1,196,104 | - |
| 254 | ENTA | Enanta Pharmaceuticals, Inc. | 402.79M | -0.93% | 24,835 | 66.98M |
| 255 | NMRA | Neumora Therapeutics, Inc. | 389.57M | -0.47% | 735,914 | - |
| 256 | NAGE | Niagen Bioscience, Inc. | 386.79M | -0.41% | 90,127 | 129.42M |
| 257 | OVID | Ovid Therapeutics Inc. | 385.07M | 0.34% | 1,021,496 | 7.25M |
| 258 | AVTX | Avalo Therapeutics, Inc. | 382.28M | -0.83% | 151,922 | 59.00K |
| 259 | XFOR | X4 Pharmaceuticals, Inc. | 380.50M | -2.45% | 77,740 | 35.11M |
| 260 | PRLD | Prelude Therapeutics Incorporated | 380.48M | 3.83% | 584,098 | 12.14M |
| 261 | MNPR | Monopar Therapeutics Inc. | 378.78M | 0.68% | 98,545 | - |
| 262 | IRD | Opus Genetics, Inc. | 377.80M | -7.65% | 558,842 | 14.20M |
| 263 | PBYI | Puma Biotechnology, Inc. | 374.96M | -1.34% | 50,095 | 228.37M |
| 264 | NAUT | Nautilus Biotechnology, Inc. | 373.37M | -2.64% | 57,680 | - |
| 265 | CABA | Cabaletta Bio, Inc. | 371.82M | -2.91% | 869,858 | - |
| 266 | BCYC | Bicycle Therapeutics plc | 368.40M | -0.84% | 83,437 | 72.59M |
| 267 | DMAC | DiaMedica Therapeutics Inc. | 365.32M | -1.02% | 33,036 | - |
| 268 | SRZN | Surrozen, Inc. | 361.83M | -0.19% | 2,436 | 3.48M |
| 269 | SLN | Silence Therapeutics plc | 359.45M | 1.06% | 30,196 | 559.00K |
| 270 | YDES | YD Bio Limited | 358.63M | -6.25% | 68,120 | 510.36K |
| 271 | RZLT | Rezolute, Inc. | 354.20M | -1.45% | 282,753 | - |
| 272 | IMRX | Immuneering Corporation | 351.71M | -2.16% | 260,634 | - |
| 273 | GLSI | Greenwich LifeSciences, Inc. | 349.13M | -9.16% | 122,189 | - |
| 274 | EDIT | Editas Medicine, Inc. | 344.51M | 0.86% | 416,411 | 40.52M |
| 275 | AVXL | Anavex Life Sciences Corp. | 338.25M | 0.27% | 355,593 | - |
| 276 | NGEN | NervGen Pharma Corp. | 328.58M | -0.25% | 37,578 | - |
| 277 | CLLS | Cellectis S.A. | 324.09M | -7.69% | 10,524 | 79.59M |
| 278 | FHTX | Foghorn Therapeutics Inc. | 319.33M | 2.84% | 35,633 | 30.91M |
| 279 | ABEO | Abeona Therapeutics Inc. | 312.63M | -0.36% | 299,947 | 5.82M |
| 280 | IKT | Inhibikase Therapeutics, Inc. | 311.02M | -0.27% | 1,191,958 | 1.00 |
| 281 | ARTV | Artiva Biotherapeutics, Inc. | 309.45M | -0.24% | 226,589 | 251.00K |
| 282 | LENZ | LENZ Therapeutics, Inc. | 306.96M | -3.83% | 249,371 | 19.09M |
| 283 | ELDN | Eledon Pharmaceuticals, Inc. | 306.90M | 1.51% | 817,495 | - |
| 284 | CHRS | Coherus Oncology, Inc. | 306.89M | 0.51% | 202,744 | 42.17M |
| 285 | NBP | NovaBridge Biosciences | 305.31M | -2.22% | 84,606 | - |
| 286 | PLYX | Polaryx Therapeutics, Inc. | 298.26M | 2.94% | 15,643 | - |
| 287 | ACIU | AC Immune SA | 296.60M | -0.67% | 86,806 | 4.51M |
| 288 | ZNTL | Zentalis Pharmaceuticals, Inc. | 293.65M | -10.78% | 1,192,154 | 26.87M |
| 289 | ALEC | Alector, Inc. | 290.25M | 2.33% | 91,697 | 21.05M |
| 290 | NERV | Minerva Neurosciences, Inc. | 289.14M | -2.01% | 26,594 | - |
| 291 | CCCC | C4 Therapeutics, Inc. | 287.86M | 1.03% | 474,377 | 35.95M |
| 292 | TARA | Protara Therapeutics, Inc. | 285.02M | -3.13% | 97,528 | - |
| 293 | HELP | Cybin Inc. | 280.20M | 1.82% | 5,552,279 | - |
| 294 | CGEN | Compugen Ltd. | 271.37M | 1.77% | 102,783 | 72.76M |
| 295 | SABS | SAB Biotherapeutics, Inc. | 271.26M | 0.26% | 86,257 | 114.70K |
| 296 | ADAG | Adagene Inc. | 261.65M | -0.25% | 257,639 | 7.67M |
| 297 | VYGR | Voyager Therapeutics, Inc. | 254.19M | 3.27% | 122,346 | 40.37M |
| 298 | OBIO | Orchestra BioMed Holdings, Inc. | 253.69M | -5.35% | 51,697 | 33.48M |
| 299 | ARCT | Arcturus Therapeutics Holdings Inc. | 251.26M | -0.11% | 137,281 | 82.03M |
| 300 | MIST | Milestone Pharmaceuticals Inc. | 250.20M | -2.86% | 1,034,446 | 1.55M |
| 301 | ACHV | Achieve Life Sciences, Inc. | 246.50M | -9.22% | 852,859 | - |
| 302 | CAMP | Camp4 Therapeutics Corporation | 239.09M | 2.56% | 9,546 | 3.50M |
| 303 | CDXS | Codexis, Inc. | 238.99M | 1.54% | 345,822 | 70.39M |
| 304 | SLGL | Sol-Gel Technologies Ltd. | 236.22M | -2.18% | 19,383 | 19.39M |
| 305 | ELTX | Elicio Therapeutics, Inc. | 234.73M | -5.83% | 56,555 | - |
| 306 | NKTX | Nkarta, Inc. | 234.55M | -5.19% | 816,945 | - |
| 307 | FENC | Fennec Pharmaceuticals Inc. | 230.64M | -1.47% | 10,624 | 44.64M |
| 308 | KROS | Keros Therapeutics, Inc. | 229.31M | -0.34% | 63,815 | 244.06M |
| 309 | NVCT | Nuvectis Pharma, Inc. | 229.15M | -2.81% | 4,479 | - |
| 310 | MGNX | MacroGenics, Inc. | 225.64M | 2.60% | 344,086 | 149.50M |
| 311 | MDWD | MediWound Ltd. | 224.37M | -1.48% | 4,697 | 16.96M |
| 312 | OABI | OmniAb, Inc. | 221.52M | -6.71% | 228,879 | 18.67M |
| 313 | ALXO | ALX Oncology Holdings Inc. | 221.10M | 0.60% | 184,214 | - |
| 314 | CNTX | Context Therapeutics Inc. | 214.54M | -3.91% | 198,728 | - |
| 315 | CRBU | Caribou Biosciences, Inc. | 213.57M | 0.45% | 659,992 | 11.16M |
| 316 | ENLV | Enlivex Ltd. | 207.66M | 1.78% | 122,885 | - |
| 317 | ABOS | Acumen Pharmaceuticals, Inc. | 207.25M | 1.77% | 112,802 | - |
| 318 | KRRO | Korro Bio, Inc. | 203.50M | -1.95% | 24,929 | 6.39M |
| 319 | SGMT | Sagimet Biosciences Inc. | 203.33M | -3.55% | 93,354 | - |
| 320 | DTIL | Precision BioSciences, Inc. | 200.49M | -1.40% | 47,542 | 34.26M |
| 321 | TNXP | Tonix Pharmaceuticals Holding Corp. | 197.46M | -0.57% | 100,015 | 13.11M |
| 322 | KPTI | Karyopharm Therapeutics Inc. | 196.13M | 1.05% | 66,364 | 146.07M |
| 323 | CNTN | Canton Strategic Holdings, Inc. | 196.03M | 0.87% | 142,415 | - |
| 324 | PRQR | ProQR Therapeutics N.V. | 192.28M | -8.29% | 452,884 | 19.19M |
| 325 | WHWK | Whitehawk Therapeutics, Inc. | 191.62M | -1.22% | 56,220 | 7.15M |
| 326 | HRTX | Heron Therapeutics, Inc. | 191.37M | 1.50% | 440,791 | 154.90M |
| 327 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 186.23M | -0.85% | 147,538 | - |
| 328 | UNCY | Unicycive Therapeutics, Inc. | 183.48M | 3.56% | 399,157 | - |
| 329 | PLX | Protalix BioTherapeutics, Inc. | 182.49M | -2.37% | 116,388 | 52.74M |
| 330 | RNAC | Cartesian Therapeutics, Inc. | 180.26M | -3.41% | 64,702 | 2.80M |
| 331 | BDTX | Black Diamond Therapeutics, Inc. | 178.17M | 1.63% | 281,888 | 70.00M |
| 332 | MENS | Jyong Biotech Ltd. | 176.87M | -5.74% | 49,270 | - |
| 333 | HURA | TuHURA Biosciences, Inc. | 176.11M | -5.14% | 139,759 | - |
| 334 | AGEN | Agenus Inc. | 170.49M | -7.31% | 790,834 | 114.20M |
| 335 | REPL | Replimune Group, Inc. | 170.10M | -5.07% | 1,600,322 | - |
| 336 | SPRO | Spero Therapeutics, Inc. | 164.41M | 3.27% | 122,687 | 66.80M |
| 337 | TNYA | Tenaya Therapeutics, Inc. | 162.92M | -4.00% | 936,608 | - |
| 338 | FATE | Fate Therapeutics, Inc. | 160.44M | -0.72% | 384,267 | 6.65M |
| 339 | CNTB | Connect Biopharma Holdings Limited | 159.39M | 0.36% | 198,260 | 64.00K |
| 340 | MOLN | Molecular Partners AG | 156.96M | 4.64% | 1,864 | 856.30K |
| 341 | TLSA | Tiziana Life Sciences Ltd | 154.43M | -2.42% | 53,428 | - |
| 342 | ORMP | Oramed Pharmaceuticals Inc. | 152.48M | -2.84% | 52,902 | 2.00M |
| 343 | IPHA | Innate Pharma S.A. | 152.35M | -4.22% | 5,764 | 10.57M |
| 344 | BMEA | Biomea Fusion, Inc. | 152.19M | -4.75% | 932,558 | - |
| 345 | HUMA | Humacyte, Inc. | 151.79M | -3.73% | 1,555,815 | 2.04M |
| 346 | GALT | Galectin Therapeutics Inc. | 150.74M | -6.53% | 198,938 | - |
| 347 | ACOG | Alpha Cognition Inc. | 148.06M | -2.02% | 12,153 | 10.22M |
| 348 | KLRS | Kalaris Therapeutics, Inc. | 141.24M | -2.53% | 24,285 | - |
| 349 | ANTX | AN2 Therapeutics, Inc. | 130.63M | 0.55% | 47,611 | - |
| 350 | NTHI | NeOnc Technologies Holdings, Inc. | 129.05M | -2.99% | 11,606 | 39.99K |
| 351 | ONCY | Oncolytics Biotech Inc. | 128.32M | -1.34% | 449,913 | - |
| 352 | KZIA | Kazia Therapeutics Limited | 125.58M | -0.99% | 67,749 | 1.27M |
| 353 | IMUX | Immunic, Inc. | 123.22M | -5.55% | 4,001,167 | - |
| 354 | CBUS | Cibus, Inc. | 121.11M | - | 184,530 | 3.64M |
| 355 | GNLX | Genelux Corporation | 120.25M | -2.87% | 36,880 | 8.00K |
| 356 | PEPG | PepGen Inc. | 119.57M | 1.76% | 255,080 | - |
| 357 | CRDF | Cardiff Oncology, Inc. | 118.96M | -3.33% | 335,817 | 593.00K |
| 358 | EQ | Equillium, Inc. | 118.87M | -8.29% | 176,107 | 4.39M |
| 359 | AARD | Aardvark Therapeutics, Inc. | 116.82M | 2.39% | 49,019 | - |
| 360 | IFRX | InflaRx N.V. | 114.22M | -0.63% | 519,918 | 34.44K |
| 361 | SEER | Seer, Inc. | 112.84M | - | 115,552 | 16.58M |
| 362 | SGMO | Sangamo Therapeutics, Inc. | 112.39M | 3.55% | 2,202,731 | 39.55M |
| 363 | COYA | Coya Therapeutics, Inc. | 112.36M | 0.21% | 52,381 | 7.95M |
| 364 | ALDX | Aldeyra Therapeutics, Inc. | 108.93M | 0.56% | 225,624 | - |
| 365 | VANI | Vivani Medical, Inc. | 108.35M | -4.48% | 143,333 | - |
| 366 | PYXS | Pyxis Oncology, Inc. | 106.81M | 2.41% | 145,465 | 13.86M |
| 367 | VRCA | Verrica Pharmaceuticals Inc. | 106.77M | -1.66% | 33,525 | 35.58M |
| 368 | PMN | ProMIS Neurosciences, Inc. | 103.22M | -0.17% | 25,736 | - |
| 369 | TTRX | Turn Therapeutics Inc. | 100.98M | -2.02% | 12,615 | - |
| 370 | GOSS | Gossamer Bio, Inc. | 100.24M | -4.24% | 1,132,488 | 48.47M |
| 371 | CGTX | Cognition Therapeutics, Inc. | 99.63M | -6.30% | 509,703 | - |
| 372 | ANIX | Anixa Biosciences, Inc. | 97.40M | -0.17% | 49,727 | - |
| 373 | INO | Inovio Pharmaceuticals, Inc. | 96.28M | -1.26% | 498,149 | 65.34K |
| 374 | COEP | Coeptis Therapeutics Holdings, Inc. | 94.90M | 4.10% | 42,983 | 1.36M |
| 375 | ACET | Adicet Bio, Inc. | 94.38M | 6.81% | 52,747 | - |
| 376 | NRXP | NRx Pharmaceuticals, Inc. | 93.49M | 10.98% | 2,017,106 | 1.23M |
| 377 | QTTB | Q32 Bio Inc. | 92.17M | 7.69% | 60,204 | 53.74M |
| 378 | SPRB | Spruce Biosciences, Inc. | 91.79M | -4.85% | 4,232 | 697.00K |
| 379 | RANI | Rani Therapeutics Holdings, Inc. | 91.74M | -3.81% | 347,858 | 1.63M |
| 380 | PYPD | PolyPid Ltd. | 91.03M | 0.63% | 31,815 | - |
| 381 | GANX | Gain Therapeutics, Inc. | 90.40M | 0.47% | 245,165 | - |
| 382 | EXOZ | eXoZymes, Inc. | 88.86M | -1.13% | 5,237 | -700.00 |
| 383 | GUTS | Fractyl Health, Inc. | 86.32M | -4.44% | 390,054 | 3.00K |
| 384 | FLNA | Filana Therapeutics, Inc. | 85.02M | 1.73% | 105,920 | - |
| 385 | MAIA | MAIA Biotechnology, Inc. | 84.94M | 3.70% | 375,569 | - |
| 386 | ATYR | aTyr Pharma, Inc. | 84.79M | 1.34% | 270,079 | 190.00K |
| 387 | LONA | LeonaBio, Inc. | 84.73M | 1.81% | 11,860 | - |
| 388 | MCRB | Seres Therapeutics, Inc. | 84.36M | -1.01% | 11,243 | 789.00K |
| 389 | OKYO | OKYO Pharma Limited | 83.97M | -3.61% | 23,247 | - |
| 390 | CSBR | Champions Oncology, Inc. | 83.18M | -0.75% | 3,570 | 57.95M |
| 391 | PLRX | Pliant Therapeutics, Inc. | 80.49M | -2.26% | 1,305,014 | - |
| 392 | ESLA | Estrella Immunopharma, Inc. | 78.50M | -2.13% | 8,232 | - |
| 393 | NRXS | NeurAxis, Inc. | 78.31M | -3.05% | 68,574 | 3.57M |
| 394 | ATHE | Alterity Therapeutics Limited | 78.18M | 15.21% | 47,875 | 4.43M |
| 395 | TCRX | TScan Therapeutics, Inc. | 78.13M | 9.24% | 807,812 | 10.33M |
| 396 | PTHS | Pelthos Therapeutics Inc. | 77.35M | 0.15% | 7,283 | 16.80M |
| 397 | PMVP | PMV Pharmaceuticals, Inc. | 76.26M | 3.62% | 116,216 | - |
| 398 | XBIT | XBiotech Inc. | 76.22M | 1.63% | 3,019 | - |
| 399 | FBIO | Fortress Biotech, Inc. | 74.71M | -1.69% | 111,089 | 63.26M |
| 400 | ACRV | Acrivon Therapeutics, Inc. | 74.20M | 7.58% | 644,324 | - |
| 401 | CUE | Cue Biopharma, Inc. | 73.79M | 24.65% | 6,537,767 | 27.47M |
| 402 | BYSI | BeyondSpring Inc. | 73.60M | 3.46% | 3,698 | 1.88M |
| 403 | IBO | Impact BioMedical Inc. | 72.94M | 4.88% | 176,651 | 32.00K |
| 404 | GRCE | Grace Therapeutics, Inc. | 72.70M | 2.13% | 690,245 | - |
| 405 | ICCC | ImmuCell Corporation | 72.46M | 0.38% | 12,169 | 27.64M |
| 406 | PDSB | PDS Biotechnology Corporation | 72.00M | -1.53% | 436,604 | - |
| 407 | MNOV | MediciNova, Inc. | 71.37M | -0.68% | 1,582 | 409.66K |
| 408 | IMMP | Immutep Limited | 70.98M | 4.45% | 5,645,823 | 5.28M |
| 409 | OKUR | OnKure Therapeutics, Inc. | 68.37M | - | 23,917 | - |
| 410 | CING | Cingulate Inc. | 67.16M | 5.96% | 304,275 | - |
| 411 | IBIO | iBio, Inc. | 66.84M | -6.07% | 380,541 | 300.00K |
| 412 | IMA | ImageneBio, Inc. | 66.44M | 0.68% | 11,205 | 800.00K |
| 413 | ANVS | Annovis Bio, Inc. | 65.27M | 1.07% | 414,584 | - |
| 414 | INKT | MiNK Therapeutics, Inc. | 64.21M | -9.01% | 35,473 | - |
| 415 | HYFT | MindWalk Holdings Corp. | 63.57M | -3.76% | 35,937 | 20.70M |
| 416 | ACTU | Actuate Therapeutics, Inc. | 61.65M | 12.55% | 713,038 | - |
| 417 | EDSA | Edesa Biotech, Inc. | 60.69M | 15.18% | 264,343 | - |
| 418 | ENTX | Entera Bio Ltd. | 58.74M | -1.56% | 47,885 | 42.00K |
| 419 | OSTX | OS Therapies Incorporated | 58.22M | -0.36% | 311,896 | - |
| 420 | TIL | Instil Bio, Inc. | 57.99M | -3.72% | 7,836 | - |
| 421 | MGX | Metagenomi Therapeutics, Inc. | 57.56M | 3.38% | 104,538 | 25.21M |
| 422 | DWTX | Dogwood Therapeutics, Inc. | 54.44M | -1.81% | 18,555 | - |
| 423 | KZR | Kezar Life Sciences, Inc. | 53.63M | -0.95% | 39,707 | - |
| 424 | MREO | Mereo BioPharma Group plc | 52.99M | -1.37% | 459,993 | 500.00K |
| 425 | ATOS | Atossa Therapeutics, Inc. | 52.49M | 4.55% | 72,516 | - |
| 426 | RADX | Radiopharm Theranostics Limited | 52.23M | 2.40% | 27,493 | 10.86M |
| 427 | NTRB | Nutriband Inc. | 51.91M | -0.70% | 2,332 | 2.28M |
| 428 | RNTX | Rein Therapeutics Inc. | 48.79M | -1.14% | 17,683 | - |
| 429 | XLO | Xilio Therapeutics, Inc. | 48.28M | -2.57% | 24,735 | 43.77M |
| 430 | HYPD | Hyperion DeFi, Inc. | 47.28M | -6.95% | 279,145 | 813.46K |
| 431 | TELO | Telomir Pharmaceuticals, Inc. | 46.76M | -6.21% | 109,676 | - |
| 432 | HOWL | Werewolf Therapeutics, Inc. | 45.68M | -0.60% | 100,755 | 1.14M |
| 433 | SNSE | Sensei Biotherapeutics, Inc. | 45.34M | 10.95% | 16,603 | - |
| 434 | RNXT | RenovoRx, Inc. | 45.05M | - | 101,856 | 1.12M |
| 435 | ATNM | Actinium Pharmaceuticals, Inc. | 44.58M | 10.00% | 423,700 | 90.00K |
| 436 | PSTV | Plus Therapeutics, Inc. | 44.05M | 0.47% | 332,748 | 5.21M |
| 437 | RLYB | Rallybio Corporation | 43.69M | 0.49% | 5,244 | 858.00K |
| 438 | NXTC | NextCure, Inc. | 43.22M | 17.58% | 52,838 | - |
| 439 | LITS | Lite Strategy, Inc. | 42.36M | -1.27% | 169,168 | - |
| 440 | ATRA | Atara Biotherapeutics, Inc. | 42.20M | -2.09% | 48,307 | 120.77M |
| 441 | ALGS | Aligos Therapeutics, Inc. | 41.03M | -0.75% | 126,931 | 2.19M |
| 442 | DARE | Daré Bioscience, Inc. | 40.04M | -6.78% | 737,774 | 1.03M |
| 443 | LIXT | Lixte Biotechnology Holdings, Inc. | 38.57M | -8.03% | 514 | - |
| 444 | VERU | Veru Inc. | 38.28M | -2.25% | 47,128 | 16.89M |
| 445 | INMB | INmune Bio Inc. | 37.62M | -2.41% | 60,212 | 50.00K |
| 446 | EVAX | Evaxion A/S | 37.11M | - | 36,860 | 7.53M |
| 447 | PLUR | Pluri Inc. | 36.38M | 4.14% | 300 | 1.34M |
| 448 | SNTI | Senti Biosciences, Inc. | 36.31M | 6.00% | 388,397 | 22.00K |
| 449 | OTLK | Outlook Therapeutics, Inc. | 36.03M | 11.38% | 4,482,055 | 205.70K |
| 450 | CELU | Celularity Inc. | 35.76M | 0.81% | 8,735 | 40.58M |
| 451 | CRVO | CervoMed Inc. | 35.74M | -3.02% | 26,338 | 4.01M |
| 452 | BOLD | Boundless Bio, Inc. | 35.07M | -0.95% | 92,175 | - |
| 453 | PTN | Palatin Technologies, Inc. | 35.00M | -2.22% | 5,237 | 8.96M |
| 454 | BCTX | BriaCell Therapeutics Corp. | 32.30M | -6.62% | 237,619 | - |
| 455 | CVM | CEL-SCI Corporation | 32.29M | -19.39% | 66,588 | - |
| 456 | DYAI | Dyadic International, Inc. | 32.06M | 0.56% | 429 | 3.09M |
| 457 | ABVC | ABVC BioPharma, Inc. | 31.79M | -2.52% | 23,172 | 797.92K |
| 458 | LGVN | Longeveron Inc. | 31.77M | -1.36% | 358,722 | 1.20M |
| 459 | TVGN | Tevogen Bio Holdings Inc. | 31.36M | 2.03% | 10,398 | - |
| 460 | TVRD | Tvardi Therapeutics, Inc. | 31.05M | -2.36% | 8,158 | - |
| 461 | APLM | Apollomics, Inc. | 30.73M | 2.95% | 341 | 6.93M |
| 462 | PBM | Psyence Biomedical Ltd. | 30.64M | 75.79% | 22,550,736 | - |
| 463 | LTRN | Lantern Pharma Inc. | 29.26M | 4.82% | 78,840 | - |
| 464 | KYNB | Kyntra Bio, Inc. | 28.56M | -3.60% | 2,094 | 6.44M |
| 465 | IGC | IGC Pharma, Inc. | 28.33M | -11.97% | 32,097,892 | 1.11M |
| 466 | NNVC | NanoViricides, Inc. | 27.86M | -5.84% | 329,113 | - |
| 467 | JSPR | Jasper Therapeutics, Inc. | 27.31M | -4.35% | 197,857 | - |
| 468 | TPST | Tempest Therapeutics, Inc. | 27.25M | -3.06% | 64,587 | - |
| 469 | MRKR | Marker Therapeutics, Inc. | 27.18M | -1.81% | 35,125 | 3.55M |
| 470 | LSTA | Lisata Therapeutics, Inc. | 27.10M | -7.12% | 25,966 | 170.00K |
| 471 | AEON | AEON Biopharma, Inc. | 27.07M | 4.90% | 125,978 | - |
| 472 | SKYE | Skye Bioscience, Inc. | 25.87M | -1.76% | 40,454 | - |
| 473 | NRSN | NeuroSense Therapeutics Ltd. | 25.71M | 2.89% | 40,421 | - |
| 474 | NEUP | Neuphoria Therapeutics Inc. | 25.55M | -0.63% | 11,591 | 14.99M |
| 475 | VTGN | Vistagen Therapeutics, Inc. | 24.89M | 0.06% | 227,880 | 789.00K |
| 476 | CRIS | Curis, Inc. | 24.59M | 1.99% | 102,237 | 9.44M |
| 477 | SER | Serina Therapeutics, Inc. | 24.57M | -2.68% | 19,395 | 130.00K |
| 478 | BRNS | Barinthus Biotherapeutics plc | 24.51M | 1.69% | 9,987 | 14.97M |
| 479 | PASG | Passage Bio, Inc. | 24.51M | -34.53% | 375,166 | - |
| 480 | LEXX | Lexaria Bioscience Corp. | 24.29M | -4.85% | 54,096 | 368.00K |
| 481 | XCUR | Exicure, Inc. | 24.17M | 0.11% | 6,099 | 500.00K |
| 482 | TRAW | Traws Pharma, Inc. | 21.79M | 8.00% | 156,839 | 2.79M |
| 483 | QNCX | Quince Therapeutics, Inc. | 21.19M | -5.11% | 917,385 | - |
| 484 | VYNE | VYNE Therapeutics Inc. | 20.99M | 3.23% | 152,657 | 570.00K |
| 485 | PLRZ | Polyrizon Ltd. | 20.63M | 1.40% | 12,141 | - |
| 486 | COCP | Cocrystal Pharma, Inc. | 20.40M | -1.99% | 123,521 | - |
| 487 | OSRH | OSR Holdings, Inc. | 19.85M | 5.14% | 170,284 | 2.91M |
| 488 | ALLR | Allarity Therapeutics, Inc. | 19.77M | 1.63% | 50,518 | 320.00K |
| 489 | TOVX | Theriva Biologics, Inc. | 19.73M | 67.19% | 424,667,275 | - |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 19.14M | -0.33% | 151,607 | 3.94M |
| 491 | QNTM | Quantum BioPharma Ltd. | 18.46M | -0.96% | 19,978 | - |
| 492 | KTTA | Pasithea Therapeutics Corp. | 18.19M | -1.75% | 1,672,022 | - |
| 493 | ICU | SeaStar Medical Holding Corporation | 16.73M | -0.24% | 32,299 | 1.23M |
| 494 | LPCN | Lipocine Inc. | 16.72M | -5.76% | 237,835 | 1.98M |
| 495 | JUNS | Jupiter Neurosciences, Inc. | 16.65M | 4.99% | 23,235 | 21.80K |
| 496 | GNTA | Genenta Science S.p.A. | 16.59M | -3.66% | 19,297 | - |
| 497 | CDT | CDT Equity Inc. | 16.06M | -4.44% | 21,736 | - |
| 498 | HIND | Vyome Holdings, Inc. | 15.76M | 1.58% | 5,585 | 319.71K |
| 499 | PHIO | Phio Pharmaceuticals Corp. | 14.64M | -2.33% | 62,104 | - |
| 500 | INAB | IN8bio, Inc. | 14.38M | 1.39% | 35,474 | - |